Results 221 to 230 of about 5,271,281 (317)

Long-term effectiveness of endoscopic and stool-based colorectal cancer screening strategies: a systematic review and network meta-analysis. [PDF]

Ther Adv Gastroenterol
Kaneko M, Sakuraba A.
europepmc   +1 more source

Public relations strategies and blood donation in Thailand : a case study of blood donors and non-donors

, 2011
Patama Satawedin
openalex   +1 more source

Diclofenac Sodium As A Topical Antimicrobial Agent: A Comprehensive Review Of Mechanisms, Formulation Strategies, Clinical Evidence, And Research Gaps

Sutha Ponnusamy
openalex   +1 more source

Social mobilization strategy

, 2011

openalex   +2 more sources

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

Molecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi, Stavros Makrodimitris, Sandra van Wilpe, Iris te Paske, Vanja de Weerd, Corine M. Beaufort, Hans M. Westgeest, Jens Voortman, Maureen J. B. Aarts, Maud Rijnders, Astrid A. M. van der Veldt, Ronald de Wit, Niven Mehra, Saskia M. Wilting, Debbie G. J. Robbrecht   +14 more
wiley   +1 more source

Improving cancer care while reducing its carbon footprint: GHG-mitigating strategies highlighted at ESMO 2025. [PDF]

BJC Rep
Delaye M, Matte P, Turpin A, Ducrot C, Dumont S, Petit PF, Piffoux M.   +6 more
europepmc   +1 more source

Peer Review #1 of "An experimental search strategy retrieves more precise results than PubMed and Google for questions about medical interventions (v0.2)"

, 2015
M Sampson
openalex   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

Strategies and Behaviour Change Techniques to Optimise Sedentary Behaviour for People with Severe Asthma: A Nominal Group Technique. [PDF]

J Clin Med
Urroz Guerrero PD, McDonald VM, Gibson PG, Majellano EC, Lewthwaite H.   +4 more
europepmc   +1 more source

The equivalence and translation strategies of the translation of discourse marker in the short stories published by Fiksi Lotus [PDF]

, 2019
Satrio Widyatama
openalex